Published in World J Orthop on June 18, 2011
Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium. PLoS One (2014) 0.90
Karyotype stability of human umbilical cord-derived mesenchymal stem cells during in vitro culture. Exp Ther Med (2014) 0.76
Differentiation of human umbilical cord mesenchymal stem cells into prostate-like epithelial cells in vivo. PLoS One (2014) 0.75
Mesenchymal stem cell in vitro labeling by hybrid fluorescent magnetic polymeric particles for application in cell tracking. Med Mol Morphol (2015) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells (2004) 4.31
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood (2001) 4.22
Matrix cells from Wharton's jelly form neurons and glia. Stem Cells (2003) 2.95
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (2003) 2.53
Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells (2007) 2.46
Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol (2006) 2.10
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod (2003) 2.09
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed (2005) 2.02
The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol (2009) 2.00
Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy (2009) 1.98
Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One (2010) 1.64
Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol (2007) 1.59
Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy (2004) 1.59
New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev (2010) 1.44
The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials (2009) 1.40
Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells (2007) 1.39
A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A (2009) 1.32
Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal (2009) 1.23
Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online (2007) 1.23
Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev (2010) 1.21
Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med (2011) 1.21
Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol (2008) 1.20
Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg (1999) 1.14
Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation. Haematologica (2004) 1.14
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells (2007) 1.14
Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into germ-like cells in vitro. J Cell Biochem (2010) 1.11
Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev (2011) 1.10
Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation (2011) 1.10
High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol (2009) 1.10
Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol (2010) 1.08
Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci (2009) 1.08
Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. J Orthop Res (2010) 1.07
Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One (2010) 1.04
Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev (2010) 1.01
Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int (2006) 1.00
Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation (2010) 0.95
The human umbilical vein: a novel scaffold for musculoskeletal soft tissue regeneration. Artif Organs (2008) 0.95
Microscale versus nanoscale scaffold architecture for mesenchymal stem cell chondrogenesis. Tissue Eng Part A (2010) 0.94
Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood. Vet Comp Orthop Traumatol (2009) 0.93
Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Stem Cells Dev (2009) 0.93
Compare the effects of chondrogenesis by culture of human mesenchymal stem cells with various type of the chondroitin sulfate C. J Biosci Bioeng (2010) 0.91
Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells. Methods Mol Biol (2011) 0.90
Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta (2010) 0.90
Chondrogenesis using mesenchymal stem cells and PCL scaffolds. J Biomed Mater Res A (2010) 0.90
Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online (2010) 0.89
Proteome analysis of human Wharton's jelly cells during in vitro expansion. Proteome Sci (2010) 0.88
Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells. Cytotherapy (2009) 0.88
In vitro differentiation of mesenchymal progenitor cells derived from porcine umbilical cord blood. Mol Cells (2007) 0.87
Effect of silicone oil on protein adsorption to hydroxyapatite in vitro and on pellicle formation in vivo. Scand J Dent Res (1990) 0.84
Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood--a comparative study. Stem Cells Dev (2010) 0.84
Chondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemically synthesized thermoreversible polymer. Chin J Physiol (2008) 0.81
A Biomimetic Material with a High Bio-responsibility for Bone Reconstruction and Tissue Engineering. J Biomater Sci Polym Ed (2011) 0.80
In vitro growth of human umbilical blood mesenchymal stem cells and their differentiation into chondrocytes and osteoblasts. Bull Exp Biol Med (2008) 0.80
Ovine cord blood accommodates multipotent mesenchymal progenitor cells. In Vivo (2006) 0.80
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells. Reprod Biol Endocrinol (2009) 0.79
Culture of bone marrow mesenchymal stem cells on engineered matrix. Methods Mol Biol (2010) 0.76
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum (2007) 1.69
Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol (2006) 1.43
Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev (2010) 1.01
Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes. J Rheumatol (2010) 0.94
Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res (2013) 0.93
Bone marrow cells immunomagnetically selected for CD271+ antigen promote in vitro the repair of articular cartilage defects. Tissue Eng Part A (2011) 0.86
Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum (2009) 0.85
Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells. Biomacromolecules (2013) 0.85
The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In Vivo. Cell Transplant (2013) 0.83
Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis. Arthritis Care Res (Hoboken) (2010) 0.81
Design of a composite drug delivery system to prolong functionality of cell-based scaffolds. Int J Pharm (2010) 0.77
SDS-CGE of proteins in microchannels made of SU-8 films. Electrophoresis (2006) 0.77
Perioperative Standard Oral Nutrition Supplements Versus Immunonutrition in Patients Undergoing Colorectal Resection in an Enhanced Recovery (ERAS) Protocol: A Multicenter Randomized Clinical Trial (SONVI Study). Medicine (Baltimore) (2016) 0.76
Brief Report: European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression Among HCV and HIV/HCV-Coinfected Patients From Northwest Spain. J Acquir Immune Defic Syndr (2016) 0.75